Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 45,358 shares at $13.03 ($591K) on 2024-01-11, disclosed to the SEC on 2024-01-12.
Scheduled sale ($591k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 22,679 | $296K | 50.0% |
| 2 | $13.03 | 22,679 | $296K | 50.0% |
| Total | $13.03 avg | 45,358 | $591K | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |
| KALV | SELL | 2023-11-21 | $41K | — | Filing → |